- Home
- Companies
- canada yukon
- coronary stent
Show results for
Refine by
Coronary Stent Suppliers Serving Yukon
30 companies found
based inWinsen, GERMANY
Stron Medical was launched in 2010 as a product line of QualiMed. With an impressive range of innovative products and a committed team of sales professionals, Stron Medical provides end-to-end solutions within Germany. QualiMed was found in 1997 as ...
The GALAXY Rapamycin-Eluting Coronary Stent System is the first carbonized stent (Inert Carbon Technology) with a completely biodegradable polymer coating which contains Rapamycin (Rapasorb™) ...
based inRanga Reddy, INDIA
Relisys Medical Devices Limited is one of the world’s leading manufacturer of cardiovascular medical devices including Coronary Stents Systems - both Bare Metal Stent Systems & Drug Eluting Stent Systems, PTCA Balloons Catheters, Angiographic ...
Highlighting Features: • Pristine+ elutes Everolimus drug which is the most preferred drug by most of the interventional cardiologists • The basic stent platform for Pristine+ is L605 Cobalt Chromium stent • The strut thickness for Pristine+ is 60 ...
based inHechingen, GERMANY
Bentley is an international medical technology company with headquarters in the South of Germany. At Bentley we are passionate about the development, manufacture and marketing of innovative products for the minimally invasive treatment of vascular ...
This extraordinary product combines a highly flexible one-layer stent graft with a low-profile balloon catheter to offer an unrivalled small guiding catheter compatibility. The cobalt-chrome stent platform is ...
based inWinsen, GERMANY
QualiMed was found in 1997 as an OEM manufacturer for implantable medical devices with a focus on the development and regulatory approval of coronary stents and their respective delivery devices. Later the business was expanded to peripheral ...
The MAGMA Rapamycin-Eluting Coronary Stent System is the first carbonized stent (Inert Carbon Technology) with a completely biodegradable polymer coating which contains Rapamycin (Rapasorb™) ...
based inChangping District, CHINA
Lepu Medical Technology ( Beijing ) Co., Ltd was established in 1999. It is specialized in developing, manufacturing and marketing high-tech medical devices and equipment. Today, Lepu Medical has grown into a global leading medical technology ...
based inTel Aviv, ISRAEL
Medinol is dedicated to the science of cardiovascular intervention. For over 20 years, we have delivered over two million coronary stents to patients worldwide. Medinol is dedicated to the science of cardiovascular intervention. For over 20 years, ...
Ridaforolimus Eluting Coronary Stent System; Excellent clinical outcomes. Redefining deliverability with a new spring tip. Low footprint cobalt-chromium design. Optimal conformability and vessel support. Elastomeric ...
based inMilpitas, CALIFORNIA (USA)
Elixir Medical is committed to transforming care of patients with heart and vascular disease through innovation. Since 2005, the company has continually sought to improve the treatment of vascular disease with: Drug-eluting coronary stent systems ...
The DESyne X2 Novolimus Eluting Coronary Stent System is a low-profile DES with high flexibility and exceptional deliverability. The ultra-thin design of its stent and polymer coating, with no ...
based inSingapore, SINGAPORE
For more than 25 years, the Biosensors International Group (“Biosensors”) has been developing and marketing critical care catheter systems and related devices used during heart surgery and intensive care treatment. Continually striving to be at the ...
BioMatrix™ Alpha presents the best in class stent platform design with unique pro-healing coating from the pioneer in abluminal biodegradable technology. It combines the proven safety of a DES with an abluminal biodegradable polymer, the ...
based inMiami Lakes, FLORIDA (USA)
Cordis is an independent, customer-focused provider of interventional cardiovascular technologies. During our 60-year history we’ve established a legacy of pioneering breakthrough technologies, including the first guiding catheters and coronary drug ...
based inSeoul, SOUTH KOREA
CG Bio Inc. is a total healthcare provider with a goal of enhancing the quality of life by offering range of innovative solutions for the spectrum of spinal disorders and wound management. Through extensive research activity, CG Bio is a leading ...
based inLeeds, UNITED KINGDOM
Founded in 2009, Leeds-based Arterius is developing a next-generation bioresorbable cardiovascular scaffold (stent) with an emerging market-leading clinical profile. The founding directors have significant experience in the development of medical ...
based inTampa, FLORIDA (USA)
Concept Medical is driving innovation in medical devices, with a focus on developing technologies for drug delivery with a strong emphasis on intellectual property. Based in Tampa, Florida; Concept Medical has always striven to find solutions to ...
ABLUMINUS DES+ designed by propriety ENVISOLUTION technology in a way that address the unmet clinical needs specially in Diabetes Mellitus and Acute Myocardial infarction patients with Coronary Artery Disease. ABLUMINUS DES+ Receives on-label ...
based inMonmouth Junction, NEW JERSEY (USA)
MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet ...
Umirolimus, a macrocyclic triene lactone Rapamycin derivative, is powerful immunosuppressant and anti-inflammatory agent. Umirolimus has highly lipophilicity and can be used agent-eluting stent (DES) ...
based inFranklin Lakes, NEW JERSEY (USA)
BD is a global medical technology company that is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. BD leads in patient and healthcare worker safety and the technologies that enable medical research ...
Tepha is developing fully absorbable stents and coatings made from TephaFLEX® material. This could allow for local drug elution while leaving no permanent residual polymer, which might address the issue of late stent thrombosis with current ...
based inBonn, GERMANY
CARDIONOVUM, a medical technology company based in Bonn, Germany, develops and commercializes innovative medical devices such as the new generation of DCB and drug-eluting stents for the treatment of coronary and peripheral artery disease. The ...
The treatment of the heart requires superior medical device safety with predictable clinical efficacy. ...
based inBaoji City, CHINA
TopTiTech is located in the east area of Baoji High-tech Industrial Development Zone, which is well-known as “Titanium Valley”in China. It is a technology-based private enterprise specializing in the production, research and development and sales of ...
1. Capillary effect; 2. Corrosion Resistance; 3. Strength and Lightweight; 4. Biocompatibility. ...
based inSurat, INDIA
SMT is a global medical device company committed to making advance medical technologies accessible to everyone around the world. With a presence in over 69 countries, SMT has achieved recognition from the Government of India for its tremendous ...
Supraflex Cruz is an amalgamation of the best-in-class features like lowest strut thickness (60 μm), biodegradable polymer and offers an extensive size ...
based inLivermore, CALIFORNIA (USA)
Advanced Bifurcation Systems has disruptive technology for left main heart disease, stenting coronary arteries at their branch points. This platform is a paradigm shift in interventional cardiology. The ABS platform is protected by more than 36 ...
based inVienna, AUSTRIA
P+F Products + Features GmbH is a medical technology company focused on research, development, and manufacture of innovative minimally invasive solutions in the field of cardiology. Our R&D capabilities are the foundation of our approach to ...
The EFIL+ Sirolimus Eluting Stent System is a combination product comprised of two regulated components: a device (a coronary stent system) and a drug product (a formulation of Sirolimus contained ...
based inChampionsGate, FLORIDA (USA)
Our purpose is to improve health of the patients all around the world with our strong, hardworking, dedicated and clinically driven biomedical solutions team. Our products and technologies are mostly focused on endovascular treatment solutions with ...
Atlas? is a coronary balloon-expandable Stainless Steel stent system consisting of everolimus particles. It is indicated for de novo and in-stent restenotic lesions in patients with ...